Shatilova, A.A. et al. 2024. Gilteritinib as a New Option for the Treatment of Relapsed/Refractory Acute Myeloid Leukemias with FLT3 Gene Mutation: A Literature Review and Three Case Reports. Clinical Oncohematology. 16, 1 (Feb. 2024), 69–79. DOI:https://doi.org/10.21320/2500-2139-2023-16-1-69-79.